(Q61917277)
Statements
Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain (English)
S Serrano
M Alvarez-Mon
F Camacho
L Fosbrook
V Guillem
J Toribio
M A Casado
J L Díaz-Pérez
J J López-López
J A Moreno-Nogueira